Nevanac 0.1% eye drop 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NS8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,622
Award facts
- Contract value 100% obligated
- $15,622.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,622.26 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Nevanac 0.1% eye drops in 3ML quantities. This is a firm fixed-price, non-set-aside contract with a completion date of February 2, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across the Department of Defense and other government healthcare systems. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veteran healthcare programs, competing on a full and open basis for federal awards. This particular delivery order represents routine medical supply procurement within the broader context of DLA's pharmaceutical prime vendor program, which ensures reliable access to essential medications and medical commodities for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9NS8?
SPE2DR26F9NS8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NS8 worth?
The government has obligated $15,622 on SPE2DR26F9NS8.
Is contract SPE2DR26F9NS8 an order under another contract?
Yes. SPE2DR26F9NS8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NS8 competed?
The extent of competition for SPE2DR26F9NS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award